These observations suggest that REP cells may transform into myofibroblasts in a stepwise manner during kidney disease progression and that Replic cells may correspond to severely myofibroblast-transformed REP cells, in which Epo and HIF2α expressions are epigenetically silenced. Here, EPO is linked to kidney disorder.